Biocryst Pharmaceuticals buy Cantor Fitzgerald
Start price
30.06.26
/
50%
€8.79
Target price
30.06.27
€25.44
Performance (%)
-4.10%
Price
27.07.26
€8.43
Summary
This prediction is currently active. With a performance of -4.10%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 30.06.27. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biocryst Pharmaceuticals | 3.869% |
| iShares Core DAX® | 0.855% |
| iShares Nasdaq 100 | -0.989% |
| iShares Nikkei 225® | -1.781% |
| iShares S&P 500 | 0.057% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (BCRX) had its price target raised by Cantor Fitzgerald from $27.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.72
15.10.25
15.10.25
€22.38
15.10.26
15.10.26
47.38%
27.07.26
27.07.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.44
29.04.25
29.04.25
€17.56
29.04.26
29.04.26
1.64%
30.04.26
30.04.26